vs
Side-by-side financial comparison of SYPRIS SOLUTIONS INC (SYPR) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
SYPRIS SOLUTIONS INC is the larger business by last-quarter revenue ($30.3M vs $20.6M, roughly 1.5× Entrada Therapeutics, Inc.). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -84.4%, a 71.5% gap on every dollar of revenue. On growth, SYPRIS SOLUTIONS INC posted the faster year-over-year revenue change (-9.5% vs -65.2%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-39.7M). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -7.7%).
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
SYPR vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.3M | $20.6M |
| Net Profit | $-3.9M | $-17.3M |
| Gross Margin | 4.6% | — |
| Operating Margin | -10.9% | -106.0% |
| Net Margin | -12.9% | -84.4% |
| Revenue YoY | -9.5% | -65.2% |
| Net Profit YoY | -2992.6% | -173.8% |
| EPS (diluted) | $-0.17 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.3M | — | ||
| Q3 25 | $28.7M | — | ||
| Q2 25 | $31.4M | — | ||
| Q1 25 | $29.5M | $20.6M | ||
| Q4 24 | $33.4M | $37.4M | ||
| Q3 24 | $35.7M | $19.6M | ||
| Q2 24 | $35.5M | $94.7M | ||
| Q1 24 | $35.6M | $59.1M |
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $517.0K | — | ||
| Q2 25 | $-2.1M | — | ||
| Q1 25 | $-899.0K | $-17.3M | ||
| Q4 24 | $135.0K | $1.1M | ||
| Q3 24 | $390.0K | $-14.0M | ||
| Q2 24 | $16.0K | $55.0M | ||
| Q1 24 | $-2.2M | $23.5M |
| Q4 25 | 4.6% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 8.2% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 16.1% | — | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | 15.9% | — | ||
| Q1 24 | 8.1% | — |
| Q4 25 | -10.9% | — | ||
| Q3 25 | -6.1% | — | ||
| Q2 25 | -4.6% | — | ||
| Q1 25 | -0.4% | -106.0% | ||
| Q4 24 | 3.9% | -15.7% | ||
| Q3 24 | 4.8% | -110.7% | ||
| Q2 24 | 3.6% | 56.4% | ||
| Q1 24 | -3.9% | 35.7% |
| Q4 25 | -12.9% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | -6.5% | — | ||
| Q1 25 | -3.0% | -84.4% | ||
| Q4 24 | 0.4% | 3.0% | ||
| Q3 24 | 1.1% | -71.7% | ||
| Q2 24 | 0.0% | 58.1% | ||
| Q1 24 | -6.2% | 39.7% |
| Q4 25 | $-0.17 | — | ||
| Q3 25 | $0.02 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.04 | $-0.42 | ||
| Q4 24 | $0.00 | $-0.20 | ||
| Q3 24 | $0.02 | $-0.35 | ||
| Q2 24 | $0.00 | $1.55 | ||
| Q1 24 | $-0.10 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.8M | $417.3M |
| Total Assets | $107.8M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | — | $185.3M | ||
| Q1 24 | — | $68.4M |
| Q4 25 | $17.8M | — | ||
| Q3 25 | $20.0M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $19.0M | $417.3M | ||
| Q4 24 | $19.6M | $428.7M | ||
| Q3 24 | $18.2M | $422.4M | ||
| Q2 24 | $19.0M | $429.9M | ||
| Q1 24 | $20.8M | $269.4M |
| Q4 25 | $107.8M | — | ||
| Q3 25 | $112.5M | — | ||
| Q2 25 | $105.8M | — | ||
| Q1 25 | $110.2M | $486.5M | ||
| Q4 24 | $119.4M | $526.3M | ||
| Q3 24 | $121.6M | $554.6M | ||
| Q2 24 | $124.2M | $582.0M | ||
| Q1 24 | $129.0M | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $-38.5M |
| Free Cash FlowOCF − Capex | $-1.5M | $-39.7M |
| FCF MarginFCF / Revenue | -5.0% | -192.9% |
| Capex IntensityCapex / Revenue | 1.3% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-6.5M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $-178.0K | — | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $-5.5M | $-38.5M | ||
| Q4 24 | $2.3M | $-31.6M | ||
| Q3 24 | $-4.8M | $-24.3M | ||
| Q2 24 | $6.2M | $39.8M | ||
| Q1 24 | $-1.7M | $-25.5M |
| Q4 25 | $-1.5M | — | ||
| Q3 25 | $-390.0K | — | ||
| Q2 25 | $941.0K | — | ||
| Q1 25 | $-5.5M | $-39.7M | ||
| Q4 24 | $1.9M | $-32.2M | ||
| Q3 24 | $-4.9M | $-24.9M | ||
| Q2 24 | $6.0M | $38.8M | ||
| Q1 24 | $-2.0M | $-26.4M |
| Q4 25 | -5.0% | — | ||
| Q3 25 | -1.4% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | -18.8% | -192.9% | ||
| Q4 24 | 5.7% | -86.2% | ||
| Q3 24 | -13.8% | -127.3% | ||
| Q2 24 | 16.8% | 41.0% | ||
| Q1 24 | -5.7% | -44.6% |
| Q4 25 | 1.3% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.0% | 5.6% | ||
| Q4 24 | 1.2% | 1.7% | ||
| Q3 24 | 0.4% | 3.3% | ||
| Q2 24 | 0.5% | 1.1% | ||
| Q1 24 | 0.9% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | -0.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 17.13× | -27.94× | ||
| Q3 24 | -12.21× | — | ||
| Q2 24 | 385.25× | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
TRDA
Segment breakdown not available.
